InvestorsHub Logo
Followers 167
Posts 35823
Boards Moderated 4
Alias Born 10/20/2019

Re: ProfitScout post# 45758

Tuesday, 03/19/2024 1:06:50 PM

Tuesday, March 19, 2024 1:06:50 PM

Post# of 45803
$NBIO - Once successfully commercialized, the Company hopes to eliminate bi-weekly weekly infusions, allowing patients to administer Pritumumab and avoid inconvenient, tedious, and uncomfortable multi hour cancer center treatment visits.
https://finance.yahoo.com/news/nascent-collaborates-hypospray-pharma-proprietary-120000958.html

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.